Vanguard Capital Management Discloses New 6.53% Stake in Moderna Inc

On April 30, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, reporting a new 6.53% ownership stake in Moderna Inc (MRNA). The filing indicates that as of the event date on March 31, 2026, Vanguard beneficially owns 25,933,824 shares of common stock. This position represents a significant increase from a previous holding of zero, marking a major new institutional investment in the biotechnology company. Vanguard reported sole dispositive power over all 25,933,824 shares, while holding sole voting power over 3,061,366 shares. The filing includes holdings from various affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. In accordance with Rule 13d-1(b), Vanguard certified that these shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This substantial position places Vanguard among the major institutional shareholders of Moderna.